Skip to main content
. 2020 Jun 15;10:63. doi: 10.1186/s13550-020-00651-z

Table 4.

Univariate analysis of [68Ga]Ga-DOTA-TOC PET/CT variables for PFS after lanreotide therapy

Variable Hazard ratio (95% CI) p value
Krenning score (2 and 3 vs. 4 ) 1.876 (0.713–4.932) 0.202
Tumour-to-liver ratio (TLR) (< 8.1 vs. ≥ 8.1) 3.329 (1.294–8.561) 0.013*
Maximum standardized uptake value (SUVmax) (< 42.94 vs. ≥ 42.94) 2.656 (1.059–6.663) 0.037*
Whole tumour volume (WTV) (≥ 58.9 cm3 vs. < 58.9 cm3) 2.721 (1.100–6.732) 0.030*
Total receptor expression (TRE) (≥ 778.5 vs. < 778.5) 1.837 (0.0.749–4.506) 0.184

*Statistically significant (p < 0.05)